公开(公告)号：US20180338467A1

公开(公告)日：2018-11-29

申请号：US15984857

申请日：2018-05-21

Applicant: NESTEC SA

Inventor： Ebenezer Satyaraj ,  Peichuan Sun ,  Scott Sherrill ,  Qinghong Li ,  Steven Hannah

IPC: A01K1/00 ,  A01K1/03

Abstract: The present disclosure provides methods for enabling an individual having a cat allergy to have a cat as a pet. Such a method can include quantitatively determining a threshold in the individual for an environmental level of an allergen produced by the cat and selecting a cat or a breed of cat that creates an environmental level of the allergen that is less than the threshold. Additionally, such a method can include lowering the allergens disseminated by the cat by treating the environment inhabited by the cat during a time period where the cat expresses elevated allergens.

公开(公告)号：US11102952B2

公开(公告)日：2021-08-31

申请号：US15984857

申请日：2018-05-21

Applicant: NESTEC SA

Inventor： Ebenezer Satyaraj ,  Peichuan Sun ,  Scott Sherrill ,  Qinghong Li ,  Steven Hannah

IPC: G01N33/68 ,  A61B5/00 ,  A01K1/00 ,  A01K1/03 ,  A01K1/01

Abstract: The present disclosure provides methods for enabling an individual having a cat allergy to have a cat as a pet. Such a method can include quantitatively determining a threshold in the individual for an environmental level of an allergen produced by the cat and selecting a cat or a breed of cat that creates an environmental level of the allergen that is less than the threshold. Additionally, such a method can include lowering the allergens disseminated by the cat by treating the environment inhabited by the cat during a time period where the cat expresses elevated allergens.

公开(公告)号：US20150175940A1

公开(公告)日：2015-06-25

申请号：US14570310

申请日：2014-12-15

Applicant: Nestec SA

Inventor： George Wells ,  Delphine Tissot-Favre ,  Ebenezer Satyaraj ,  Juergen Eck ,  Daniel Meyer ,  Torsten Ertongur-Fauth ,  Alexander Pelzer ,  Scott Sherrill ,  Peichuan Sun

IPC: C11D3/386 ,  A01K1/015 ,  A61L9/00

CPC classification number: C11D3/38609 ,  A01K1/0155 ,  A23K20/189 ,  A23K50/40 ,  A23K50/42 ,  A23K50/48 ,  A61K38/00 ,  A61L9/00 ,  C11D3/386 ,  C11D3/38618 ,  C11D11/0011

Abstract: Formulations, compositions and products for reducing allergenic Fel d 1 from the environment are disclosed. The formulations include at least one protease that interacts with the Fel d 1 and substantially degrades allergenic epitopes on the Fel d 1. Methods of using the formulations for reducing or eliminating allergenic Fel d 1 from the environment are also disclosed.

Abstract translation: 公开了用于降低环境中致敏性Fel d 1的制剂，组合物和产品。 该制剂包括与Fel d 1相互作用的至少一种蛋白酶，并且在Fel d 1上基本上降解过敏表位。还公开了使用该制剂减少或消除来自环境的过敏性Fel d 1的方法。

公开(公告)号：US20140107218A1

公开(公告)日：2014-04-17

申请号：US14052997

申请日：2013-10-14

Applicant: NESTEC SA

Inventor： Scott Sherrill ,  Wei Wang

IPC: A61K31/132 ,  A61K45/06

CPC classification number: A61K31/132 ,  A61K45/06 ,  A61K2300/00

Abstract: The invention provides novel methods for maintaining eye health and ameliorating ophthalmic maladies in animals by administering to the animals an ophthalmic malady ameliorating amount of one or more polyamines. Generally, the polyamines are administered to the animals in amounts of from about 1 to about 200 mg/kg/day to ameliorate maladies such as cataracts and cloudy eye.

Abstract translation: 本发明提供了通过向动物施用改善剂量的一种或多种多胺的眼部疾病来维持眼睛健康和改善动物眼部疾病的新方法。 通常，多胺以约1至约200mg / kg /天的量施用于动物以改善诸如白内障和浑浊眼睛的疾病。